🇺🇸 combination of high-dose rosuvastatin and ezetimibe in United States

combination of high-dose rosuvastatin and ezetimibe (combination of high-dose rosuvastatin and ezetimibe) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

combination of high-dose rosuvastatin and ezetimibe in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is combination of high-dose rosuvastatin and ezetimibe approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for combination of high-dose rosuvastatin and ezetimibe in United States?

Korea University Anam Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.